­
­
­
­

Inventi Impact: Gastroenterology

Articles

  • Inventi:hgst/33048/20
    Extra-Hepatic Comorbidity Burden Significantly Increases 90-Day Mortality in Patients with Cirrhosis and High Model for Endstage Liver Disease
    Research 2021 : January - March
    Scott Coppel, Karan Mathur, Burcin Ekser Kavish R Patidar, Eric Orman, Archita P Desai, Eduardo Vilar Gomez, Chandrashekhar Kubal, Naga Chalasani, Lauren Nephew, Marwan Ghabril

    Background: We examined how extra-hepatic comorbidity burden impacts mortality in patients with cirrhosis\nreferred for liver transplantation (LT).\nMethods: Adults with cirrhosis evaluated for their first LT in 2012 were followed through their clinical course with\nlast follow up in 2019. Extra-hepatic comorbidity burden was measured using the Charlson Comorbidity Index (CCI).\nThe endpoints were 90-day transplant free survival (Cox-Proportional Hazard regression), and overall mortality\n(competing risk analysis).........................................

    How to Cite this Article
    Attribution/ CC Compliant Citation: Coppel, Scott, et al.\n\"Extra-hepatic comorbidity burden significantly increases\n90-day mortality in patients with cirrhosis and high model\nfor endstage liver disease.\" BMC gastroenterology 20.1\n(2020): 1-11.\nhttps://doi.org/10.1186/s12876-020-01448-z\nhttp://creativecommons.org/licenses/by/4.0/\nSome formatting elements, header, footer, logos, dates and\npagination were modified while adapting this article.
    Download Full Text